Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends

3Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This resource guides prescribers, pharmacists, and regulators with an update on the recent expansion of basic and clinical knowledge that forms a framework for understanding cutaneous reactions. This understanding will lead, in turn, to better outcomes and decisions in treatment and management, both in the clinic and in the life cycle of drug development. The skin is a common target for adverse drug events and even mild rashes can be part of life-threatening syndromes. Patients and practitioners often face important decisions about therapy after a drug eruption, including treatment, cross-reactivity with future pharmaceuticals, genetic considerations and dealing with long-term sequelae after a reaction. An international team of experts and leaders in the field share their story and insights into the scientific details and relevant clinical context.

Cite

CITATION STYLE

APA

Shear, N. H., & Dodiuk-Gad, R. P. (2018). Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends. Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends (pp. 1–314). Springer Singapore. https://doi.org/10.1007/978-981-13-1489-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free